2-[6-(benzimidazol-1-id-2-yl)-2-pyridinyl]-4-(pyridin-2-ylmethyl)benzimidazol-3-ide;2-[6-(3H-indazol-3-id-2-yl)-2-pyridinyl]-4-(pyridin-2-ylmethyl)-3H-indazol-3-ide;2-methyl-4-[[2-[6-[4-methyl-5-(trifluoromethyl)-3H-pyrazol-3-id-2-yl]-2-pyridinyl]-5-(trifluoromethyl)-3H-pyrazol-3-id-4-yl]methyl]-2H-1,3-benzothiazol-3-ide;platinum;tetrakis(platinum(2+));2-[4-(2-pyridin-2-ylethyl)-5-(trifluoromethyl)-3H-pyrazol-3-id-2-yl]-6-[3-(trifluoromethyl)-5H-pyrazol-5-id-1-yl]pyridine;7-(pyridin-2-ylmethyl)-2-[6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]-2-pyridinyl]indol-1-ide

C116H73F15N29Pt5S-3 — CID 160947033

About 2-[6-(benzimidazol-1-id-2-yl)-2-pyridinyl]-4-(pyridin-2-ylmethyl)benzimidazol-3-ide;2-[6-(3H-indazol-3-id-2-yl)-2-pyridinyl]-4-(pyridin-2-ylmethyl)-3H-indazol-3-ide;2-methyl-4-[[2-[6-[4-methyl-5-(trifluoromethyl)-3H-pyrazol-3-id-2-yl]-2-pyridinyl]-5-(trifluoromethyl)-3H-pyrazol-3-id-4-yl]methyl]-2H-1,3-benzothiazol-3-ide;platinum;tetrakis(platinum(2+));2-[4-(2-pyridin-2-ylethyl)-5-(trifluoromethyl)-3H-pyrazol-3-id-2-yl]-6-[3-(trifluoromethyl)-5H-pyrazol-5-id-1-yl]pyridine;7-(pyridin-2-ylmethyl)-2-[6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]-2-pyridinyl]indol-1-ide

2-[6-(benzimidazol-1-id-2-yl)-2-pyridinyl]-4-(pyridin-2-ylmethyl)benzimidazol-3-ide;2-[6-(3H-indazol-3-id-2-yl)-2-pyridinyl]-4-(pyridin-2-ylmethyl)-3H-indazol-3-ide;2-methyl-4-[[2-[6-[4-methyl-5-(trifluoromethyl)-3H-pyrazol-3-id-2-yl]-2-pyridinyl]-5-(trifluoromethyl)-3H-pyrazol-3-id-4-yl]methyl]-2H-1,3-benzothiazol-3-ide;platinum;tetrakis(platinum(2+));2-[4-(2-pyridin-2-ylethyl)-5-(trifluoromethyl)-3H-pyrazol-3-id-2-yl]-6-[3-(trifluoromethyl)-5H-pyrazol-5-id-1-yl]pyridine;7-(pyridin-2-ylmethyl)-2-[6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]-2-pyridinyl]indol-1-ide (PubChem CID 160947033) has the molecular formula C116H73F15N29Pt5S-3 and a molecular weight of 3165.49 g/mol. Its IUPAC name is 2-[6-(benzimidazol-1-id-2-yl)-2-pyridinyl]-4-(pyridin-2-ylmethyl)benzimidazol-3-ide;2-[6-(3H-indazol-3-id-2-yl)-2-pyridinyl]-4-(pyridin-2-ylmethyl)-3H-indazol-3-ide;2-methyl-4-[[2-[6-[4-methyl-5-(trifluoromethyl)-3H-pyrazol-3-id-2-yl]-2-pyridinyl]-5-(trifluoromethyl)-3H-pyrazol-3-id-4-yl]methyl]-2H-1,3-benzothiazol-3-ide;platinum;tetrakis(platinum(2+));2-[4-(2-pyridin-2-ylethyl)-5-(trifluoromethyl)-3H-pyrazol-3-id-2-yl]-6-[3-(trifluoromethyl)-5H-pyrazol-5-id-1-yl]pyridine;7-(pyridin-2-ylmethyl)-2-[6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]-2-pyridinyl]indol-1-ide.

Molecular Properties

• Compound Name: 2-[6-(benzimidazol-1-id-2-yl)-2-pyridinyl]-4-(pyridin-2-ylmethyl)benzimidazol-3-ide;2-[6-(3H-indazol-3-id-2-yl)-2-pyridinyl]-4-(pyridin-2-ylmethyl)-3H-indazol-3-ide;2-methyl-4-[[2-[6-[4-methyl-5-(trifluoromethyl)-3H-pyrazol-3-id-2-yl]-2-pyridinyl]-5-(trifluoromethyl)-3H-pyrazol-3-id-4-yl]methyl]-2H-1,3-benzothiazol-3-ide;platinum;tetrakis(platinum(2+));2-[4-(2-pyridin-2-ylethyl)-5-(trifluoromethyl)-3H-pyrazol-3-id-2-yl]-6-[3-(trifluoromethyl)-5H-pyrazol-5-id-1-yl]pyridine;7-(pyridin-2-ylmethyl)-2-[6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]-2-pyridinyl]indol-1-ide
• PubChem CID: 160947033
• Molecular Formula: C116H73F15N29Pt5S-3
• Molecular Weight: 3165.49 g/mol
• Exact Mass: 3163.43
• IUPAC Name: 2-[6-(benzimidazol-1-id-2-yl)-2-pyridinyl]-4-(pyridin-2-ylmethyl)benzimidazol-3-ide;2-[6-(3H-indazol-3-id-2-yl)-2-pyridinyl]-4-(pyridin-2-ylmethyl)-3H-indazol-3-ide;2-methyl-4-[[2-[6-[4-methyl-5-(trifluoromethyl)-3H-pyrazol-3-id-2-yl]-2-pyridinyl]-5-(trifluoromethyl)-3H-pyrazol-3-id-4-yl]methyl]-2H-1,3-benzothiazol-3-ide;platinum;tetrakis(platinum(2+));2-[4-(2-pyridin-2-ylethyl)-5-(trifluoromethyl)-3H-pyrazol-3-id-2-yl]-6-[3-(trifluoromethyl)-5H-pyrazol-5-id-1-yl]pyridine;7-(pyridin-2-ylmethyl)-2-[6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]-2-pyridinyl]indol-1-ide
• SMILES: Cc1[c-]n(-c2cccc(-n3[c-]c(Cc4cccc5c4[N-]C(C)S5)c(C(F)(F)F)n3)n2)nc1C(F)(F)F.FC(F)(F)c1c[c-]n(-c2cccc(-n3[c-]c(CCc4ccccn4)c(C(F)(F)F)n3)n2)n1.FC(F)(F)c1cc(-c2cccc(-c3cc4cccc(Cc5ccccn5)c4[n-]3)n2)[n-]n1.[Pt+2].[Pt+2].[Pt+2].[Pt+2].[Pt].[c-]1c2ccccc2nn1-c1cccc(-n2[c-]c3c(Cc4ccccn4)cccc3n2)n1.c1ccc(Cc2cccc3nc(-c4cccc(-c5nc6ccccc6[n-]5)n4)[n-]c23)nc1
• InChI: InChI=1S/2C25H16N6.C23H15F6N6S.C23H14F3N5.C20H12F6N6.5Pt/c1-2-10-19-18(9-1)28-24(29-19)21-12-6-13-22(27-21)25-30-20-11-5-7-16(23(20)31-25)15-17-8-3-4-14-26-17;1-2-10-22-19(7-1)16-30(28-22)24-12-6-13-25(27-24)31-17-21-18(8-5-11-23(21)29-31)15-20-9-3-4-14-26-20;1-12-10-34(32-20(12)22(24,25)26)17-7-4-8-18(31-17)35-11-15(21(33-35)23(27,28)29)9-14-5-3-6-16-19(14)30-13(2)36-16;24-23(25,26)21-13-20(30-31-21)18-9-4-8-17(28-18)19-12-15-6-3-5-14(22(15)29-19)11-16-7-1-2-10-27-16;21-19(22,23)15-9-11-31(29-15)16-5-3-6-17(28-16)32-12-13(18(30-32)20(24,25)26)7-8-14-4-1-2-10-27-14;;;;;/h2*1-14H,15H2;3-8,13H,9H2,1-2H3;1-10,12-13H,11H2;1-6,9-10H,7-8H2;;;;;/q2*-2;-3;2*-2;;4*+2
• InChIKey: IOFPWHUQGACEST-UHFFFAOYSA-N
• XLogP: 24.35
• TPSA: 332.10 Ų
• H-Bond Acceptors: 25
• Rotatable Bonds: 21
• Heavy Atoms: 166
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	3165.49
LogP ≤ 5	24.35
H-Bond Donors ≤ 5	0
H-Bond Acceptors ≤ 10	25

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 2-[6-(benzimidazol-1-id-2-yl)-2-pyridinyl]-4-(pyridin-2-ylmethyl)benzimidazol-3-ide;2-[6-(3H-indazol-3-id-2-yl)-2-pyridinyl]-4-(pyridin-2-ylmethyl)-3H-indazol-3-ide;2-methyl-4-[[2-[6-[4-methyl-5-(trifluoromethyl)-3H-pyrazol-3-id-2-yl]-2-pyridinyl]-5-(trifluoromethyl)-3H-pyrazol-3-id-4-yl]methyl]-2H-1,3-benzothiazol-3-ide;platinum;tetrakis(platinum(2+));2-[4-(2-pyridin-2-ylethyl)-5-(trifluoromethyl)-3H-pyrazol-3-id-2-yl]-6-[3-(trifluoromethyl)-5H-pyrazol-5-id-1-yl]pyridine;7-(pyridin-2-ylmethyl)-2-[6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]-2-pyridinyl]indol-1-ide?

The IUPAC name of 2-[6-(benzimidazol-1-id-2-yl)-2-pyridinyl]-4-(pyridin-2-ylmethyl)benzimidazol-3-ide;2-[6-(3H-indazol-3-id-2-yl)-2-pyridinyl]-4-(pyridin-2-ylmethyl)-3H-indazol-3-ide;2-methyl-4-[[2-[6-[4-methyl-5-(trifluoromethyl)-3H-pyrazol-3-id-2-yl]-2-pyridinyl]-5-(trifluoromethyl)-3H-pyrazol-3-id-4-yl]methyl]-2H-1,3-benzothiazol-3-ide;platinum;tetrakis(platinum(2+));2-[4-(2-pyridin-2-ylethyl)-5-(trifluoromethyl)-3H-pyrazol-3-id-2-yl]-6-[3-(trifluoromethyl)-5H-pyrazol-5-id-1-yl]pyridine;7-(pyridin-2-ylmethyl)-2-[6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]-2-pyridinyl]indol-1-ide (CID 160947033) is 2-[6-(benzimidazol-1-id-2-yl)-2-pyridinyl]-4-(pyridin-2-ylmethyl)benzimidazol-3-ide;2-[6-(3H-indazol-3-id-2-yl)-2-pyridinyl]-4-(pyridin-2-ylmethyl)-3H-indazol-3-ide;2-methyl-4-[[2-[6-[4-methyl-5-(trifluoromethyl)-3H-pyrazol-3-id-2-yl]-2-pyridinyl]-5-(trifluoromethyl)-3H-pyrazol-3-id-4-yl]methyl]-2H-1,3-benzothiazol-3-ide;platinum;tetrakis(platinum(2+));2-[4-(2-pyridin-2-ylethyl)-5-(trifluoromethyl)-3H-pyrazol-3-id-2-yl]-6-[3-(trifluoromethyl)-5H-pyrazol-5-id-1-yl]pyridine;7-(pyridin-2-ylmethyl)-2-[6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]-2-pyridinyl]indol-1-ide.

What is the SMILES notation for 2-[6-(benzimidazol-1-id-2-yl)-2-pyridinyl]-4-(pyridin-2-ylmethyl)benzimidazol-3-ide;2-[6-(3H-indazol-3-id-2-yl)-2-pyridinyl]-4-(pyridin-2-ylmethyl)-3H-indazol-3-ide;2-methyl-4-[[2-[6-[4-methyl-5-(trifluoromethyl)-3H-pyrazol-3-id-2-yl]-2-pyridinyl]-5-(trifluoromethyl)-3H-pyrazol-3-id-4-yl]methyl]-2H-1,3-benzothiazol-3-ide;platinum;tetrakis(platinum(2+));2-[4-(2-pyridin-2-ylethyl)-5-(trifluoromethyl)-3H-pyrazol-3-id-2-yl]-6-[3-(trifluoromethyl)-5H-pyrazol-5-id-1-yl]pyridine;7-(pyridin-2-ylmethyl)-2-[6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]-2-pyridinyl]indol-1-ide?

The canonical SMILES for 2-[6-(benzimidazol-1-id-2-yl)-2-pyridinyl]-4-(pyridin-2-ylmethyl)benzimidazol-3-ide;2-[6-(3H-indazol-3-id-2-yl)-2-pyridinyl]-4-(pyridin-2-ylmethyl)-3H-indazol-3-ide;2-methyl-4-[[2-[6-[4-methyl-5-(trifluoromethyl)-3H-pyrazol-3-id-2-yl]-2-pyridinyl]-5-(trifluoromethyl)-3H-pyrazol-3-id-4-yl]methyl]-2H-1,3-benzothiazol-3-ide;platinum;tetrakis(platinum(2+));2-[4-(2-pyridin-2-ylethyl)-5-(trifluoromethyl)-3H-pyrazol-3-id-2-yl]-6-[3-(trifluoromethyl)-5H-pyrazol-5-id-1-yl]pyridine;7-(pyridin-2-ylmethyl)-2-[6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]-2-pyridinyl]indol-1-ide is Cc1[c-]n(-c2cccc(-n3[c-]c(Cc4cccc5c4[N-]C(C)S5)c(C(F)(F)F)n3)n2)nc1C(F)(F)F.FC(F)(F)c1c[c-]n(-c2cccc(-n3[c-]c(CCc4ccccn4)c(C(F)(F)F)n3)n2)n1.FC(F)(F)c1cc(-c2cccc(-c3cc4cccc(Cc5ccccn5)c4[n-]3)n2)[n-]n1.[Pt+2].[Pt+2].[Pt+2].[Pt+2].[Pt].[c-]1c2ccccc2nn1-c1cccc(-n2[c-]c3c(Cc4ccccn4)cccc3n2)n1.c1ccc(Cc2cccc3nc(-c4cccc(-c5nc6ccccc6[n-]5)n4)[n-]c23)nc1.

What is the InChIKey of 2-[6-(benzimidazol-1-id-2-yl)-2-pyridinyl]-4-(pyridin-2-ylmethyl)benzimidazol-3-ide;2-[6-(3H-indazol-3-id-2-yl)-2-pyridinyl]-4-(pyridin-2-ylmethyl)-3H-indazol-3-ide;2-methyl-4-[[2-[6-[4-methyl-5-(trifluoromethyl)-3H-pyrazol-3-id-2-yl]-2-pyridinyl]-5-(trifluoromethyl)-3H-pyrazol-3-id-4-yl]methyl]-2H-1,3-benzothiazol-3-ide;platinum;tetrakis(platinum(2+));2-[4-(2-pyridin-2-ylethyl)-5-(trifluoromethyl)-3H-pyrazol-3-id-2-yl]-6-[3-(trifluoromethyl)-5H-pyrazol-5-id-1-yl]pyridine;7-(pyridin-2-ylmethyl)-2-[6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]-2-pyridinyl]indol-1-ide?

The InChIKey is IOFPWHUQGACEST-UHFFFAOYSA-N. The full InChI is InChI=1S/2C25H16N6.C23H15F6N6S.C23H14F3N5.C20H12F6N6.5Pt/c1-2-10-19-18(9-1)28-24(29-19)21-12-6-13-22(27-21)25-30-20-11-5-7-16(23(20)31-25)15-17-8-3-4-14-26-17;1-2-10-22-19(7-1)16-30(28-22)24-12-6-13-25(27-24)31-17-21-18(8-5-11-23(21)29-31)15-20-9-3-4-14-26-20;1-12-10-34(32-20(12)22(24,25)26)17-7-4-8-18(31-17)35-11-15(21(33-35)23(27,28)29)9-14-5-3-6-16-19(14)30-13(2)36-16;24-23(25,26)21-13-20(30-31-21)18-9-4-8-17(28-18)19-12-15-6-3-5-14(22(15)29-19)11-16-7-1-2-10-27-16;21-19(22,23)15-9-11-31(29-15)16-5-3-6-17(28-16)32-12-13(18(30-32)20(24,25)26)7-8-14-4-1-2-10-27-14;;;;;/h2*1-14H,15H2;3-8,13H,9H2,1-2H3;1-10,12-13H,11H2;1-6,9-10H,7-8H2;;;;;/q2*-2;-3;2*-2;;4*+2.

What are the key properties of 2-[6-(benzimidazol-1-id-2-yl)-2-pyridinyl]-4-(pyridin-2-ylmethyl)benzimidazol-3-ide;2-[6-(3H-indazol-3-id-2-yl)-2-pyridinyl]-4-(pyridin-2-ylmethyl)-3H-indazol-3-ide;2-methyl-4-[[2-[6-[4-methyl-5-(trifluoromethyl)-3H-pyrazol-3-id-2-yl]-2-pyridinyl]-5-(trifluoromethyl)-3H-pyrazol-3-id-4-yl]methyl]-2H-1,3-benzothiazol-3-ide;platinum;tetrakis(platinum(2+));2-[4-(2-pyridin-2-ylethyl)-5-(trifluoromethyl)-3H-pyrazol-3-id-2-yl]-6-[3-(trifluoromethyl)-5H-pyrazol-5-id-1-yl]pyridine;7-(pyridin-2-ylmethyl)-2-[6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]-2-pyridinyl]indol-1-ide?

2-[6-(benzimidazol-1-id-2-yl)-2-pyridinyl]-4-(pyridin-2-ylmethyl)benzimidazol-3-ide;2-[6-(3H-indazol-3-id-2-yl)-2-pyridinyl]-4-(pyridin-2-ylmethyl)-3H-indazol-3-ide;2-methyl-4-[[2-[6-[4-methyl-5-(trifluoromethyl)-3H-pyrazol-3-id-2-yl]-2-pyridinyl]-5-(trifluoromethyl)-3H-pyrazol-3-id-4-yl]methyl]-2H-1,3-benzothiazol-3-ide;platinum;tetrakis(platinum(2+));2-[4-(2-pyridin-2-ylethyl)-5-(trifluoromethyl)-3H-pyrazol-3-id-2-yl]-6-[3-(trifluoromethyl)-5H-pyrazol-5-id-1-yl]pyridine;7-(pyridin-2-ylmethyl)-2-[6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]-2-pyridinyl]indol-1-ide has a molecular weight of 3165.49 g/mol, XLogP of 24.35, 21 rotatable bonds, 0 hydrogen bond donors, and 25 hydrogen bond acceptors.

Where does this data come from?

All data for 2-[6-(benzimidazol-1-id-2-yl)-2-pyridinyl]-4-(pyridin-2-ylmethyl)benzimidazol-3-ide;2-[6-(3H-indazol-3-id-2-yl)-2-pyridinyl]-4-(pyridin-2-ylmethyl)-3H-indazol-3-ide;2-methyl-4-[[2-[6-[4-methyl-5-(trifluoromethyl)-3H-pyrazol-3-id-2-yl]-2-pyridinyl]-5-(trifluoromethyl)-3H-pyrazol-3-id-4-yl]methyl]-2H-1,3-benzothiazol-3-ide;platinum;tetrakis(platinum(2+));2-[4-(2-pyridin-2-ylethyl)-5-(trifluoromethyl)-3H-pyrazol-3-id-2-yl]-6-[3-(trifluoromethyl)-5H-pyrazol-5-id-1-yl]pyridine;7-(pyridin-2-ylmethyl)-2-[6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]-2-pyridinyl]indol-1-ide is sourced from PubChem (CID 160947033), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).